Dysregulation of IMP2 is linked to several metabolic dysfunctions, including wound healing, type 2 diabetes (T2D), obesity, fatty liver disease, and cancer, highlighting its potential as a therapeutic target [13]. The gene discussed is IGF2BP2; the disease is fatty liver disease.